Medtech industry wants more clarity on new UK market access office
This article was originally published in SRA
Medical device industry alliance MedTech Europe broadly welcomes plans by UK health technology assessment body NICE to set up a new Office for Market Access but says it wants to gain a better understanding of how the office will operate.
You may also be interested in...
Zolgensma should receive a conditional approval, says the European Medicines Agency’s drug evaluation committee, the CHMP.
The health technology assessment institute is taking a virtual approach to meetings and has said that it can provide free fast-track advice for companies developing novel diagnostics or therapeutics for the coronavirus.
Companies are due to learn this week whether the European Medicines Agency will fast-track its review of their soon-to-be-filed EU marketing applications.